ABBVIE INC.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
ABBV Company Description
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
ABBV Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ABBV Smart Score
Score Breakdown
ABBV Company Description
Show More
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox). Show Less
$ABBV is featured in our Tom Carper strategy.
See All StrategiesAll
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of ABBV by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ABBV's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on ABBV's company Twitter account
WallStreetBets
Number of mentions of ABBV in WallStreetBets Daily Discussion
ABBV News
Recent insights relating to ABBV
CNBC Recommendations
Recent picks made for ABBV stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ABBV
Corporate Flights
Flights by private jets registered to ABBV
Our Analysis